Biofrontera Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $18.9M
- Price
- $1.48
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 446.3K
About
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Quick stats
Shares outstanding12.8M
Computed float11.3M
Float / shares88.3%
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001858685
AI Summary
AI-generated1/11
majorbullishearnings
Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth
Biofrontera reported record Q2 revenue of $12.0 million, up 33% year-over-year, driven by steady Ameluz demand and improved pricing, while gross margin expanded to 80%.
The company significantly narrowed its net loss to $0.6 million from $5.3 million in the prior-year period, bringing Adjusted EBITDA to within $0.2 million of breakeven and reducing first-half cash burn by 76%.
Management highlighted progress toward cash flow breakeven in 2026 and noted a PDUFA date in late September for the sBCC indication, though order timing was impacted by an ITC exclusion order on the RhodoLED XL lamp.
Red flags
- Cash balance of $4.7 million remains low despite reduced burn rate
- ITC exclusion order on RhodoLED XL lamp impacting order timing